A new study has found that "Patients with rheumatoid arthritis and overweight/obesity who took GLP-1RAs showed greater reductions in disease activity and cardiovascular risks vs those who did not initiate treatment:" https://www.rheumatologyadvisor.com/news/glp-1ras-linked-to-reduced-ra-disease-activity/.
Have you tried a GLP-1 or are you interested? Let us know.